Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After Birth

Name: Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After Birth
Published: 2015
License: Public Domain

Sanofi Pasteur, a Sanofi Company · 2015

ClinicalTrials.gov · Datasets · License: Public Domain · 2015

Open Source ↗

diphtheria hepatitis-b pertussis poliomyelitis

diphtheria, tetanus, pertussis, poliomyelitis, hepatitis b, haemophilus influenzae type b, dtap-ipv-hep b-prp-t combined vaccine (hexaxim®), interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents